Silence Therapeutics plc (SLN)

Silence Therapeutics Revenue

Silence Therapeutics had revenue of 12.41M GBP in the quarter ending March 31, 2024, with 9.07% growth. This brings the company's revenue in the last twelve months to 26.41M, up 14.05% year-over-year. In the year 2023, Silence Therapeutics had annual revenue of 25.38M with 44.99% growth.

• Revenue (ttm): 26.41M GBP
• Revenue Growth: +14.05%
• P/S Ratio: 28.88
• Revenue / Employee: 242,266 GBP
• Employees: 109
• Market Cap: 977.63M USD

Revenue Chart

* This company reports financials in GBP.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	25.38M	7.87M	44.99%
Dec 31, 2022	17.50M	5.09M	40.97%
Dec 31, 2021	12.42M	6.94M	126.59%
Dec 31, 2020	5.48M	5.24M	2,145.49%
Dec 31, 2019	244.00K	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.